Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T23316 |
SB 218795
|
Neurokinin receptor | GPCR/G Protein; Neuroscience |
SB 218795 是一种有效的特异性 NK3 拮抗剂,对 hNK3 的 Ki 为 13 nM,比 hNK2 和 hNK1 的特异性高约 90 倍和 7000 倍。 | |||
T37933 |
15-keto Latanoprost (free acid)
|
Others | Others |
15-keto Latanoprost is a potential metabolite of latanoprost when administered to animals. 15-keto Latanoprost is also one of the common minor impurities found in commercial preparations of the bulk drug compound. Although much less potent that the parent compound latanoprost, 15-keto latanoprost still retains the ability to produce a small but measurable decrease (1 mm Hg) in the intraocular pressure of normal cynomolgus monkeys when administered at a dose of 1 μg/eye. 15-keto Latanoprost is al... | |||
T37934 |
15-keto-17-phenyl trinor Prostaglandin F2α
15-keto-17-phenyl trinor Prostaglandin F2α |
Others | Others |
Bimatoprost is an F-series prostaglandin (PG) analog which has been approved for use as an ocular hypotensive drug. Oxidation of the C-15 hydroxyl group and amide hydrolysis of Bimatoprost produces 15-keto-17-phenyl trinor PGF2α. 15-keto-17-phenyl trinor PGF2α is a potential metabolite of bimatoprost when administered to animals. 15-keto PG analogs are potential minor impurities in commercial preparations of their corresponding bulk drug compounds. Although much less potent that the parent compo... | |||
T37932 |
15-keto Latanoprost
|
Others | Others |
Latanoprost is an F-series prostaglandin (PG) analog which has been approved for use as an ocular hypotensive drug. Oxidation of the C-15 hydroxyl group without isopropyl ester hydrolysis produces 15-keto latanoprost. 15-keto Latanoprost is a potential metabolite of latanoprost when administered to animals. 15-keto Latanoprost is also one of the common minor impurities found in commercial preparations of the bulk drug compound. Although much less potent that the parent compound latanoprost, 15-k... |